Comment
doi: 10.1056/NEJMc2301380.
Lecanemab in Early Alzheimer's Disease. Reply
Affiliations
- PMID: 37099355
- DOI: 10.1056/NEJMc2301380
Item in Clipboard
Comment
Lecanemab in Early Alzheimer's Disease. Reply
N Engl J Med.
.
No abstract available
Comment on
-
Lecanemab in Early Alzheimer's Disease.N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. N Engl J Med. 2023. PMID: 36449413 Clinical Trial.
Similar articles
-
Lecanemab in Early Alzheimer's Disease.N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. N Engl J Med. 2023. PMID: 36449413 Clinical Trial.
-
Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease.J Prev Alzheimers Dis. 2025 May;12(5):100160. doi: 10.1016/j.tjpad.2025.100160. Epub 2025 Apr 5. J Prev Alzheimers Dis. 2025. PMID: 40189473 Free PMC article. Clinical Trial.
-
Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis.Ageing Res Rev. 2025 Feb;104:102620. doi: 10.1016/j.arr.2024.102620. Epub 2024 Dec 3. Ageing Res Rev. 2025. PMID: 39638097
-
Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease.J Prev Alzheimers Dis. 2023;10(4):771-777. doi: 10.14283/jpad.2023.123. J Prev Alzheimers Dis. 2023. PMID: 37874099 Clinical Trial.
-
A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer's disease.Expert Opin Biol Ther. 2024 Nov;24(11):1261-1269. doi: 10.1080/14712598.2024.2416947. Epub 2024 Nov 12. Expert Opin Biol Ther. 2024. PMID: 39432414
Cited by
-
Alzheimer's Disease: Cellular and Pharmacological Aspects.Geriatrics (Basel). 2024 Jun 22;9(4):86. doi: 10.3390/geriatrics9040086. Geriatrics (Basel). 2024. PMID: 39051250 Free PMC article. Review.
-
Perspective: Minimally clinically important "symptomatic" benefit associated with disease modification resulting from anti-amyloid immunotherapy.Alzheimers Dement (N Y). 2025 Jan 20;11(1):e70035. doi: 10.1002/trc2.70035. eCollection 2025 Jan-Mar. Alzheimers Dement (N Y). 2025. PMID: 39839076 Free PMC article.
-
Elevated Amyloid-β PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.J Alzheimers Dis. 2024;97(3):1161-1171. doi: 10.3233/JAD-230950. J Alzheimers Dis. 2024. PMID: 38306055 Free PMC article.
-
Achieving Inclusion in Pharmacological Clinical Trials for Alzheimer's Disease.Curr Top Behav Neurosci. 2025;69:229-242. doi: 10.1007/7854_2024_522. Curr Top Behav Neurosci. 2025. PMID: 39668311 Review.
-
A novel binary hashing for agricultural scenery classification.Sci Rep. 2024 Nov 11;14(1):27602. doi: 10.1038/s41598-024-77685-z. Sci Rep. 2024. PMID: 39528553 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
